{
  "report_rows": [
    {
      "kpi": "Adjusted EPS",
      "prediction": "BEAT",
      "answer": "pred ~$0.86 vs. cons $0.85",
      "confidence": "MEDIUM"
    },
    {
      "kpi": "Revenue",
      "prediction": "IN-LINE",
      "answer": "pred ~$1.97B vs. cons $1.97B",
      "confidence": "MEDIUM"
    },
    {
      "kpi": "Adjusted EBITDA margin",
      "prediction": "IN-LINE",
      "answer": "pred ~26.4% vs. cons 26.5%",
      "confidence": "MEDIUM"
    }
  ],
  "guide_rows": [
    {
      "kpi": "FY26 organic revenue growth",
      "prediction": "UNCHANGED",
      "answer": "guide ~1.0% vs. cons 1.0% (FY26)",
      "confidence": "HIGH"
    },
    {
      "kpi": "FY26 adjusted EBITDA",
      "prediction": "UNCHANGED",
      "answer": "guide ~$2.16B vs. cons $2.16B (FY26)",
      "confidence": "HIGH"
    },
    {
      "kpi": "IT&S adjusted EBITDA margin exit-rate commentary",
      "prediction": "BETTER",
      "answer": "guide ~30.0% vs. cons 29.6% (2H26)",
      "confidence": "MEDIUM"
    }
  ],
  "day1_residual_pct": 1.5,
  "day1_confidence": "MEDIUM",
  "day5_residual_pct": 0.5,
  "day5_path": "FADE",
  "day5_rationale": "A modest ~$0.01 EPS beat and credible 2H IT&S-margin exit-rate support an initial ~1.5% residual gain, but unchanged ~$2.16B FY26 EBITDA guidance versus ~$2.16B consensus leaves out-period estimates largely intact; the market will retain concern over the back-half margin concentration, causing the move to fade toward ~0.5% by day five.",
  "day5_confidence": "MEDIUM"
}